Skip to main content
. 2020 Apr 16;5(2):e000635. doi: 10.1136/esmoopen-2019-000635

Figure 3.

Figure 3

Sacrum metastases not amenable to surgical resection are treated with SBRT and 223-Ra with improvement in the patient’s quality of life. (A) A 15-year-old patient (patient B in tables 1–3) with osteosarcoma recurrence in the right sacrum evidenced on SPECT. This patient was treated with SBRT and six cycles of 223-Ra. The patient was able to continue to attend school while undergoing SBRT. The post-treatment SPECT revealed reduced radiotracer uptake in the sacral disease. (B) A 17-year-old patient (patient K in tables 1–3) with osteosarcoma recurrent in the left sacrum associated with severe pain. This patient was treated with SBRT and six cycles of 223-Ra. Again, the post-treatment SPECT showed reduced radiotracer uptake in the sacral disease. Complete and durable resolution of pain without local relapse was observed in both patients. PTV, planning target volume; SBRT, stereotactic body radiation therapy; SPECT, single-photon emission computed tomography.